Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases-Reference-Cited by-同舟云学术

Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases

Published:2008-01 Issue:1 Volume:206 Page:96-106
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Reddy Srinevas K.,Morse Michael A.,Hurwitz Herbert I.,Bendell Johanna C.,Gan Tong J.,Hill Steven E.,Clary Bryan M.

Publisher

Elsevier BV

Subject

Surgery

Reference41 articles.

1. The biology of VEGF and its receptors;Ferrera;Nat Med,2003

2. Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer;Ellis;Semin Oncol,2006

3. Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer;Gordon;J Clin Oncol,2001

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;New Engl J Med,2004

5. Bevacizumab in combination with chemotherapy: first-line treatment for patients with metastatic colorectal cancer;Hochester;Semin Oncol,2006

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

2. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study;HPB;2024-02

3. Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023);Clinical Surgical Oncology;2023-06

4. Stage IV Colorectal Cancer Management and Treatment;Journal of Clinical Medicine;2023-03-06

5. Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature;World Journal of Gastrointestinal Oncology;2021-09-15